Today according to the International Disease Classifier IDC-10, there are
more than 12 thousand human diseases in the world, combined into 21 classes.
Some of them are striking, widespread and have familiar symptoms. But a great many of diseases can
not be revealed quickly and easy, and as everybody knows, early diagnostics of the disease
significantly increases chance of recovery and allows to prevent disease transition into chronic
stage. At the same time many human diseases even easy recognizable represent serious hidden threat to
Viral and infectious diseases, heart diseases, infarctions, strokes and cancer become more
complicated tasks for modern medicine.
Improvement of sanitary conditions and nutrition culture has significant influence on the health of
population, as a result infant mortality decreased and more and more people start to live till
childbearing age. Thanks to discovery of antibiotics widespread infections, for example, tuberculosis,
stopped to threaten the life of people. As a result expected life span increased approximately from 40
years old in XIX century to more than 70 years at present. But spread of diseases the frequency of
which is increased with ages became an inevitable consequence of population development and aging.
Every 6th tellurian in any period of his/her life gets cancer disease, 40% of diseased die
in the first year after diagnose. According to data of international statistics: today every 72
seconds this disease affects one person, and every 97 seconds one oncological patient dies.
Today curability of oncological diseases makes only 26%. As predicted by the International
Agency on Cancer Study up to 2015 the planet will be overwhelmed by epidemic of oncological diseases.
Every year 15 million of cases will be registered and annually 10 million of patients will die.
What are the main reasons of cancer? If we try to combine all known external factors,
provoking cancer (as well as any other malignant tumor), then we will receive extremely
simple picture – these are physical factors (ionizing radiation, ultraviolet, etc.), chemical factors
(carcinogenic substances) and biological factors (some viruses).
Originally they all result into damage of DNA structure, the consequence of which is usually
activation of oncogene and the cell gains “immortality”. There are also internal reasons of
cancer. Most often the matter concerns inherited predisposition to cancer. Usually the matter
concerns hereditary decrease of ability to DNA recovery, or immunity decrease.
All three methods of treatment are used in cancer treatment: surgical,
chemotherapeutical and radial. The choice of treatment method or their combination depends on many
factors. As a rule modern surgical treatment is organo-preserving and little-traumatic. Modern
chemotherapeutics as a rule is protocol that allows achieving maximum effect with minimum
consequences. Radial influence is used usually in combination with other methods, by strict
indications and established protocols. On the whole each kind of cancer requires individual approach
to the treatment and its success depends in the first place on the time of detection.
Cancer prophylaxis is directed first of all on revealing pre-cancerous conditions
and also on susceptibility to it in order to include patients in risk group. Regular
screening investigations should be carried out in risk groups. Thanks to this in Japan, for example,
stomach cancer although is revealed approximately 2 times frequently but mortality due to it is 2
times lower than in other countries.
Cancer is not an inevitability that is why execution of elementary preventive measures decreases
risk of disease incidence dozens of times. In common comprehension prophylaxis should be directed on
rendering counteraction to cancer development by method of decrease of contact with
carcinogens (giving up smoking, normalization of nutrition, etc.), and also improvement of
anticancer protection (deactivation of carcinogens, activation of DNA and immunity reparation
systems and regular intake of oncoprotectors, especially for risk group).
Theoretically 80% of cancer can be prevented. Pharmacologists all over the world constantly develop
new products that are able even not to cure the patient completely then to improve the quality of
his/her life for many years, one of such directions – is creation of neoantiogenesis
blockers, i.e. substances, able to disturb feeding of cancerous growth.
One of these agents are new «GRINIZATION™» products worked out by World
Grinization System Inc., USA for rehabilitation of oncological patients, for treatment of
chronic hepatitides of different etiology and metabolic syndrome.
The Nation’s Health Institute carries out medical and biological maintenance of
«GRINIZATION™» program in Ukraine.
On the basis of the results of medical investigations reports on
«GRINIZATION™» products, they can be recommended for combines use with
classic methods of oncology treatment, for use in monotherapy as neoantiogrenesis blockers, and also
as oncoprotectors for risk group.
Chronic viral hepatitides – group of infectious diseases that carry the threat to
the mankind not less then cancer. Today in this group of diseases the early diagnostics is also
difficult and there are no safe treatment methods. Viral hepatitides B (VHB) and C (VHC) should be
emphasized. VHB in most cases has better prognosis of cure, but its prevalence all over the world
took huge scales. The share of VHC in incidence is slightly smaller, but we cannot be
completely sure of it as this type of hepatitis proceeds insensibly and is called “tender killer” not
in vein – liver injury in case of VHC is progressing quickly in outwardly healthy people and
often leads to liver cirrhosis or even to hepatocellular carcinoma.
Chronic viral hepatitides due to epidemiology peculiarities affect most frequently young people,
many of them in case of absence of adequate treatment die till 40 – 45 years old from liver cirrhosis
or cancer. Alcohol, simultaneous infection of several viruses of hepatitis and HIV can speed up the
progress of disease.
Thus, acute phase in case of VHC proceeds latently very often, in this case the
person does not know for a long period of time about infection up to the moment of significant liver
complications or accidental revealing of increased content of liver enzymes in blood or liver increase
(by the results of US). The liver itself is the organ that does not respond with pain for occurring
pathological processes. Patient with viral hepatitis can feel only undue fatigability, decreased
ability to work, etc. for a long period of time whereas liver injury is slowly, gradually,
progressing. Due to this reason patients come in view of doctor most often with already formed viral
hepatitis or with developed cirrhosis.
Chronic viral hepatitides make up to 70-80% of all hepatitides. Beside viral hepatitides, of great
importance are alcohol, toxic, drug-induced hepatitides, especially due to increased
for the last time tendency to polypragmasia and uncontrolled intake of medicines by
patients. Especially dangerous is combination of these types of hepatitides with viral liver injury.
Treatment of viral hepatitides is complicated task. Viruses, as it is known, - are
intracellular pathogens, which are practically impossible to be influenced by most medicines.
Pathogens of these diseases persist in organism, in addition they are not only in
hepatocytes, but also in other cells (for example, in vessels endothelium, kidneys). That is why the
problem of viral hepatitides could not be solved even due to liver transplantation – the virus
affects donor liver very quickly. Besides there are criteria according to which the necessity of
pharmacotherapy and the most rational scheme of treatment are determined. In a number of clinical
situations the most expedient is only to observe patients, in other cases it is necessary to start
active antiviral treatment.
Rational treatment of chronic viral hepatitides today means the use of interferons and nucleosides
analogues. Pegylated interferons – is the largest achievement of the last years in
treatment of viral hepatitides. The main contraindications to antiviral therapy are
severe accompanying diseases (of cardiovascular system, lungs, kidneys, decompensated diabetes
mellitus, psychic disturbances), autoimmune pathology, decompensated liver cirrhosis, drug addiction.
The presence of antibodies to microsomes of thyroid gland is the risk factor of further development of
thyroid gland dysfunction.
Low efficacy (35-40 % of recovery of patients with VHB and 52 % - with VHC) against the background
of great number of severe complications and side effects, and also duration of
therapy (from 24 up to 48 weeks and more) together with high cost of pegylated
interferons, set the task before the doctors to find more effective, sparing and available
for patients methods of treatment of chronic hepatitides.
The scientists of The Nation’s Health Institute, together with the leading patient
care institutions in the field of infectious diseases and gastroenterology, introduce new method of
treatment of chronic hepatitides of different etiology in Ukraine - «GRINIZATION™».
«GRINIZATION™» products have pronounced immunomodulatory and antiviral action
with total absence of side effects and contraindications. Duration of therapy makes from 8 up
to 16 weeks.
Comparing the results of medical investigation reports the use of «GRINIZATION™» method can
be recommended for application in combination with pegylated interferons, to decrease side effects,
and also as monotherapy, when interferonotherapy is not prescribed or there is a risk of development
of side complications.
For cardiologists the use of «GRINIZATION™» met
hod can be recommended as prophylaxis of atherosclerosis and acute coronary
syndrome development, rehabilitation of post-stroke and post-infarction states. The use of
method normalizes the following indices: whole protein, protein fractions, complex investigation of
lipid metabolism (triglycerides, cholesterol, HDL, LDL, VLDL), C-reactive protein (quantitative
method), homocysteine, glycemia level, glucose tolerance test.
At present research on study of method efficacy in case of diabetes mellitus, pancreatitis,
nonspecific ulcerative colitis and other autoimmune diseases is carried out.